Metraipolis › archive › dc_39b1f163dcef
Efficacy of DMARDs Therapy on the Disease Activity and Gene Expression Levels of FoxO1, FoxO3, Runx1, and Runx3 in Early Rheumatoid Arthritis Patients: A… — Europe PMC PMID:41132193
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41132193
- DOI
- 10.1002/hsr2.71388
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T04:22:04.137Z
- SHA-256 of the archived text
f7689ff33f30456444d1e236f2311198139c68f703fd5bfa085afacdb23d5b49- Stable URL of this page
https://metraipolis.com/documento/dc_39b1f163dcef
How to cite
Efficacy of DMARDs Therapy on the Disease Activity and Gene Expression Levels of FoxO1, FoxO3, Runx1, and Runx3 in Early Rheumatoid Arthritis Patients: A… — Europe PMC PMID:41132193 — Europe PMC (en), https://europepmc.org/article/MED/41132193 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_39b1f163dcef (Metraipolis archive dc_39b1f163dcef, sha256 f7689ff33f30456444d1e236f2311198139c68f703fd5bfa085afacdb23d5b49)
BibTeX
@misc{dc39b1f163dcef,
title = {Efficacy of DMARDs Therapy on the Disease Activity and Gene Expression Levels of FoxO1, FoxO3, Runx1, and Runx3 in Early Rheumatoid Arthritis Patients: A… — Europe PMC PMID:41132193},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41132193},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_39b1f163dcef; sha256 f7689ff33f30456444d1e236f2311198139c68f703fd5bfa085afacdb23d5b49},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41132193. Agents can read the archived copy with the MCP tool read_document.